Influenza Virus PB1 and Neuraminidase Gene Segments Can Cosegregate during Vaccine Reassortment Driven by Interactions in the PB1 Coding Region

ABSTRACT Egg-grown influenza vaccine yields are maximized by infection with a seed virus produced by “classical reassortment” of a seasonal isolate with a highly egg-adapted strain. Seed viruses are selected based on a high-growth phenotype and the presence of the seasonal hemagglutinin (HA) and neuraminidase (NA) surface antigens. Retrospective analysis of H3N2 vaccine seed viruses indicated that, unlike other internal proteins that were predominantly derived from the high-growth parent A/Puerto Rico/8/34 (PR8), the polymerase subunit PB1 could be derived from either parent depending on the seasonal strain. We have recently shown that A/Udorn/307/72 (Udorn) models a seasonal isolate that yields reassortants bearing the seasonal PB1 gene. This is despite the fact that the reverse genetics-derived virus that includes Udorn PB1 with Udorn HA and NA on a PR8 background has inferior growth compared to the corresponding virus with PR8 PB1. Here we use competitive plasmid transfections to investigate the mechanisms driving selection of a less fit virus and show that the Udorn PB1 gene segment cosegregates with the Udorn NA gene segment. Analysis of chimeric PB1 genes revealed that the coselection of NA and PB1 segments was not directed through the previously identified packaging sequences but through interactions involving the internal coding region of the PB1 gene. This study identifies associations between viral genes that can direct selection in classical reassortment for vaccine production and which may also be of relevance to the gene constellations observed in past antigenic shift events where creation of a pandemic virus has involved reassortment. IMPORTANCE Influenza vaccine must be produced and administered in a timely manner in order to provide protection during the winter season, and poor-growing vaccine seed viruses can compromise this process. To maximize vaccine yields, manufacturers create hybrid influenza viruses with gene segments encoding the surface antigens from a seasonal virus isolate, important for immunity, and others from a virus with high growth properties. This involves coinfection of cells with both parent viruses and selection of dominant progeny bearing the seasonal antigens. We show that this method of creating hybrid viruses does not necessarily select for the best yielding virus because preferential pairing of gene segments when progeny viruses are produced determines the genetic makeup of the hybrids. This not only has implications for how hybrid viruses are selected for vaccine production but also sheds light on what drives and limits hybrid gene combinations that arise in nature, leading to pandemics.

[1]  C. Isel,et al.  A functional sequence-specific interaction between influenza A virus genomic RNA segments , 2013, Proceedings of the National Academy of Sciences.

[2]  C. Isel,et al.  Critical role of segment-specific packaging signals in genetic reassortment of influenza A viruses , 2013, Proceedings of the National Academy of Sciences.

[3]  N. Heaton,et al.  Colocalization of Different Influenza Viral RNA Segments in the Cytoplasm before Viral Budding as Shown by Single-molecule Sensitivity FISH Analysis , 2013, PLoS pathogens.

[4]  S. Rockman,et al.  The Source of the PB1 Gene in Influenza Vaccine Reassortants Selectively Alters the Hemagglutinin Content of the Resulting Seed Virus , 2013, Journal of Virology.

[5]  C. Isel,et al.  Interaction network linking the human H3N2 influenza A virus genomic RNA segments. , 2012, Vaccine.

[6]  C. Isel,et al.  An in vitro network of intermolecular interactions between viral RNA segments of an avian H5N2 influenza A virus: comparison with a human H3N2 virus , 2012, Nucleic acids research.

[7]  Kazuhiro Aoyama,et al.  Three-dimensional analysis of ribonucleoprotein complexes in influenza A virus , 2012, Nature Communications.

[8]  C. Isel,et al.  A supramolecular assembly formed by influenza A virus genomic RNA segments , 2011, Nucleic acids research.

[9]  J. Gog,et al.  Overlapping signals for translational regulation and packaging of influenza A virus segment 2 , 2011, Nucleic acids research.

[10]  D. Bucher,et al.  Gene Constellation of Influenza A Virus Reassortants with High Growth Phenotype Prepared as Seed Candidates for Vaccine Production , 2011, PloS one.

[11]  B. Lina,et al.  Genetic content of Influenza H3N2 vaccine seeds , 2010, PLoS currents.

[12]  Gavin J. D. Smith,et al.  Origins and evolutionary genomics of the 2009 swine-origin H1N1 influenza A epidemic , 2009, Nature.

[13]  Wendy S. Barclay,et al.  A Complicated Message: Identification of a Novel PB1-Related Protein Translated from Influenza A Virus Segment 2 mRNA , 2009, Journal of Virology.

[14]  H. Ly,et al.  Mutational Analyses of Packaging Signals in Influenza Virus PA, PB1, and PB2 Genomic RNA Segments , 2007, Journal of Virology.

[15]  Kelli L Boyd,et al.  Expression of the 1918 influenza A virus PB1-F2 enhances the pathogenesis of viral and secondary bacterial pneumonia. , 2007, Cell host & microbe.

[16]  Yukiko Muramoto,et al.  Hierarchy among Viral RNA (vRNA) Segments in Their Role in vRNA Incorporation into Influenza A Virions , 2006, Journal of Virology.

[17]  Yuying Liang,et al.  cis-Acting Packaging Signals in the Influenza Virus PB1, PB2, and PA Genomic RNA Segments , 2005, Journal of Virology.

[18]  C. Gerdil The annual production cycle for influenza vaccine. , 2003, Vaccine.

[19]  W. Greene,et al.  A sensitive and specific enzyme-based assay detecting HIV-1 virion fusion in primary T lymphocytes , 2002, Nature Biotechnology.

[20]  Jonathan W. Yewdell,et al.  A novel influenza A virus mitochondrial protein that induces cell death , 2001, Nature Medicine.

[21]  R. Webster,et al.  A DNA transfection system for generation of influenza A virus from eight plasmids. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[22]  R. Webster,et al.  Avian-to-human transmission of the PB1 gene of influenza A viruses in the 1957 and 1968 pandemics , 1989, Journal of virology.

[23]  G. Tannock,et al.  Relative immunogenicity of the cold-adapted influenza virus A/Ann Arbor/6/60 (A/AA/6/60-ca), recombinants of A/AA/6/60-ca, and parental strains with similar surface antigens , 1984, Infection and immunity.

[24]  C. Scholtissek,et al.  On the origin of the human influenza virus subtypes H2N2 and H3N2. , 1978, Virology.

[25]  E. D. Kilbourne,et al.  Genetic studies of influenza viruses. I. Viral morphology and growth capacity as exchangeable genetic traits. Rapid in ovo adaptation of early passage Asian strain isolates by combination with PR8. , 1960 .

[26]  E. D. Kilbourne Future influenza vaccines and the use of genetic recombinants. , 1969, Bulletin of the World Health Organization.